These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1976142)

  • 21. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over the counter sales of histamine-2 receptor antagonists.
    Petersen H
    Scand J Gastroenterol Suppl; 1988; 155():20-2. PubMed ID: 2907682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug interactions between prescribed and over-the-counter medication.
    Honig PK; Gillespie BK
    Drug Saf; 1995 Nov; 13(5):296-303. PubMed ID: 8785017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of a switch from prescription to over-the-counter status for allergy drugs.
    Brass EP
    Curr Allergy Asthma Rep; 2004 May; 4(3):245-50. PubMed ID: 15056408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of self-care with over-the-counter medications.
    Soller RW
    Clin Ther; 1998; 20 Suppl C():C134-40. PubMed ID: 9915100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy.
    Simoni-Wastila L; Stuart BC; Shaffer T
    J Am Geriatr Soc; 2006 Oct; 54(10):1543-9. PubMed ID: 17038072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?
    Holt S
    Drugs; 1994 Jan; 47(1):1-11. PubMed ID: 7510616
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
    Sullivan PW; Nair KV; Patel BV
    Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.
    Sullivan PW; Nichol MB
    Value Health; 2004; 7(4):402-12. PubMed ID: 15449632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are prescribed and over-the-counter medicines economic substitutes? A study of the effects of health insurance on medicine choices by the elderly.
    Stuart B; Grana J
    Med Care; 1995 May; 33(5):487-501. PubMed ID: 7739273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoting safe and effective use of OTC medications: CHPA-GSA National Summit.
    Albert SM; Bix L; Bridgeman MM; Carstensen LL; Dyer-Chamberlain M; Neafsey PJ; Wolf MS
    Gerontologist; 2014 Dec; 54(6):909-18. PubMed ID: 24846884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching from prescription to over-the counter medications: a consumer and managed care perspective.
    Pawaskar MD; Balkrishnan R
    Manag Care Interface; 2007 Jan; 20(1):42-7. PubMed ID: 17310652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.
    Redstone HA; Barrowman N; Veldhuyzen Van Zanten SJ
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1291-9. PubMed ID: 11552898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?
    Shiffman S; Sweeney CT
    Health Policy; 2008 Apr; 86(1):17-26. PubMed ID: 17935827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies.
    Allescher HD; Böckenhoff A; Knapp G; Wienbeck M; Hartung J
    Scand J Gastroenterol; 2001 Sep; 36(9):934-41. PubMed ID: 11521983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly?
    Francis SA; Barnett N; Denham M
    Drugs Aging; 2005; 22(5):361-70. PubMed ID: 15903349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Functional dyspepsia: the past, the present and the Rome III classification].
    Buzás GM
    Orv Hetil; 2007 Aug; 148(33):1573-9. PubMed ID: 17686677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world Data and Evidence to support a switch in status from Prescription drug to Over the Counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM.
    Kühler TC; Ateka A; Lassoued Z; Routhier FX; Mékary-Sawaya S
    Clin Ther; 2024 Mar; 46(3):208-216. PubMed ID: 38278703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Self medication with antacids and H2 antihistaminics].
    Martin E
    Pharm Unserer Zeit; 2007; 36(1):52-8. PubMed ID: 17283751
    [No Abstract]   [Full Text] [Related]  

  • 40. Over-the-counter availability of H2-receptor antagonists and gastric cancer.
    Yoshikawa I; Murata I; Otsuki M
    Ann Intern Med; 2000 Oct; 133(8):659. PubMed ID: 11033604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.